COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 2373: Articles 23721-23730  | Next

Risk factors for outbreaks of COVID-19 in care homes following hospital discharge: a national cohort analysis
Emmerson, C., Adamson, J. P., Turner, D., Gravenor, M. B., Salmon, J., Cottrell, S., Middleton, V., Thomas, B., Mason, B., Williams, C. J.
10.1101/2020.08.24.20168955 — Posted: 2020-08-26 Discussion: Onsite
Molecular dynamics reveals complex compensatory effects of ionic strength on the SARS-CoV-2 Spike/hACE-2 interaction
Souza, A. S. d., Rivera, J. D., Medeiros, V., Ge, P., Souza, R. F. d., Farah, C. S., Ulrich, H., Marana, S. R., Kopke Salinas, R., Guzzo, C. R.
10.1101/2020.08.25.267351 — Posted: 2020-08-26
Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis
Johnson, B. A., Xie, X., Kalveram, B., Lokugamage, K. G., Muruato, A., Zou, J., Zhang, X., Juelich, T., Smith, J. K., Zhang, L., Schindewolf, C., Vu, M. N., Vanderheiden, A., Plante, J. A., Plante, K. S., Lee, B., Weaver, S., Suthar, M., Routh, A. L., Ren, P. L., Ku, Z., An, Z., Debbink, K., Shi, P. Y., Freiberg, A. N., Menachery, V. D.
10.1101/2020.08.26.268854 — Posted: 2020-08-26 Discussion: Onsite | Offsite
The SARS-CoV-2 Spike mutation D614G increases entry fitness across a range of ACE2 levels, directly outcompetes the wild type, and is preferentially incorporated into trimers
Michaud, W. A., Boland, G. M., Rabi, S. A.
10.1101/2020.08.25.267500 — Posted: 2020-08-26 Discussion: Onsite
Epitopes targeted by T cells in convalescent COVID-19 patients
Quadeer, A. A., Ahmed, S. F., McKay, M. R.
10.1101/2020.08.26.267724 — Posted: 2020-08-26
AI aided design of epitope-based vaccine for the induction of cellular immune responses against SARS-CoV-2
Mazzocco, G., Niemiec, I., Myronov, A., Skoczylas, P., Kaczmarczyk, J., Sanecka-Duin, A., Gruba, K., Krol, P., Drwal, M., Szczepanik, M., Pyrc, K., Stepniak, P.
10.1101/2020.08.26.267997 — Posted: 2020-08-26
Identification of a polymorphism in the N gene of SARS-CoV-2 that adversely impacts detection by a widely-used RT-PCR assay
Vanaerschot, M., Mann, S. A., Webber, J. T., Kamm, J., Bell, S. M., Bell, J., Hong, S. N., Nguyen, M. P., Chan, L. Y., Bhatt, K. D., Tan, M., Detweiler, A. M., Espinosa, A., Wu, W., Batson, J., Dynerman, D., CLIAHUB Consortium, , Wadford, D. A., Puschnik, A., Neff, N., Ahyong, V., Miller, S., Ayscue, P., Tato, C. M., Paul, S., Kistler, A., DeRisi, J. L., Crawford, E. D.
10.1101/2020.08.25.265074 — Posted: 2020-08-26
A unique view of SARS-CoV-2 through the lens of ORF8 protein
Hassan, S. S., Ghosh, S., Attrish, D., Choudhury, P. P., Seyran, M., Pizzol, D., Adadi, P., Abd El Aziz, T. M., Soares, A., Kandimalla, R., Lundstrom, K., Tambuwala, M., Aljabali, A. A., Lal, A., Azad, G. K., Uversky, V. N., Sherchan, S. P., Baetas-da-Cruz, W., Uhal, B., Rezaei, N., Brufsky, A.
10.1101/2020.08.25.267328 — Posted: 2020-08-26
Multi-species ELISA for the detection of antibodies against SARS-CoV-2 in animals
Wernike, K., Aebischer, A., Michelitsch, A., Hoffmann, D., Freuling, C., Balkema-Buschmann, A., Graaf, A., Mueller, T., Osterrieder, N., Rissmann, M., Rubbenstroth, D., Schoen, J., Schulz, C., Trimpert, J., Ulrich, L., Volz, A., Mettenleiter, T., Beer, M.
10.1101/2020.08.26.266825 — Posted: 2020-08-26
Inhibiting coronavirus replication in cultured cells by chemical ER stress
Shaban, M. S., Mueller, C., Mayr-Buro, C., Weiser, H., Albert, B. V., Weber, A., Linne, U., Hain, T., Babayev, I., Karl, N., Hofmann, N., Becker, S., Herold, S., Schmitz, M. L., Ziebuhr, J., Kracht, M.
10.1101/2020.08.26.266304 — Posted: 2020-08-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).